Browse studies

Find your next paid study

64 recruiting studies matching your filters

Genetic Analysis of Immune Disorders

The purposes of this study are to 1) identify the genes responsible for certain immune disorders, 2) learn about the medical problems they cause, and 3) learn …

DOK 8STAT1GATA2+2 more

Estimated

~$10 – $675

National Institute of Allergy and Infectious Diseases (NIAID)NCT00001467

Metabolic Profiling of Immune Responses in Immune-Mediated Diseases

Background: The immune system is the part of the body that fights infection. Some people have immune deficiencies that cause skin rashes, make them get sick o…

Primary ImmunodeficiencyPsoriasisAtopic Dermatitis+1 more

Estimated

~$10 – $675

National Institute of Allergy and Infectious Diseases (NIAID)NCT04864886

Phase 2

A Phase 2/3, Randomized, Active-Controlled, Open-Label (Phase 2) and Double-Blind (Phase 3) Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Once Daily in Treatment-Naïve Adult Participants Living With HIV-1

Researchers are looking for new ways to treat HIV-1 (Human Immunodeficiency Virus Type 1). The usual (standard) treatment for HIV-1 is antiretroviral therapy (…

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT07266831

Observational

Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study

This study uses a rapid randomized controlled trial (RCT) design to examine HIV pre-exposure prophylaxis (PrEP) delivered through telehealth. This study will d…

Human Immunodeficiency Virus

Estimated

~$10 – $6,250

Emory UniversityNCT07821671

Phase 1

Phase 1/2 Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM

Background: Warts, hypogammaglobulinemia, infections and myelokathexis syndrome (WHIMs) is a rare disorder that affects the immune system. People with WHIMs c…

WHIMWartsHypogammaglobulinemia+2 more

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT07775313

Phase 3

A Multicenter, Randomized, Controlled, Open-label, Group-Sequential, Phase 3 Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infection Prophylaxis Compared With Secondary Infection Prophylaxis in Adult Subjects With Multiple Myeloma Receiving B-Cell Maturation AntigenxCD3-Directed Bispecific Antibody Therapy

Multiple myeloma is a cancer of the plasma cells in the bone marrow. The main aim of this study is to learn how well the Immune Globulin Infusion (human), 10 …

Multiple MyelomaSecondary Immunodeficiency

Phase II Study Assessing the Effect of BK Specific CTL Lines Generated by Ex Vivo Expansion in Patients With BK Virus Infection and JC Virus Infection

This phase II trial studies how well donor cytotoxic T lymphocytes work in treating patients with malignancies with BK and/or JC virus. Cytotoxic T lymphocytes…

Acquired Immunodeficiency SyndromeBK Virus InfectionHuman Immunodeficiency Virus+5 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT02479698

Observational

PositiveLinks for Youth (PL4Y) for Texas: Effectiveness, Feasibility, and Acceptability of mHealth to Improve Care Outcomes for Young Adults With HIV

The goal of this interventional clinical trial is to test an an app, PL4Y, installed on a mobile smartphone to see if it can help participants aged 18-29 years…

Human Immunodeficiency VirusHIV

Estimated

~$10 – $6,250

The University of Texas Health Science Center at San AntonioNCT07804602

Observational

Project ARTEMIS: A Mechanistic Clinical Trial of Neuroimmune Pathways.

The purpose of this research is to understand how chronic stress affects the way our brain and immune systems function, and in turn how this affects the way pe…

Stimulant UseHuman Immunodeficiency Virus (HIV)Depression

Estimated

~$10 – $6,250

Wake Forest University Health SciencesNCT06814275

Phase 4

A Multi-Center, Single-Arm, Open-Label, Prospective, Phase 4 Study to Investigate the Safety and Efficacy of Rapidly Restarting Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Viremic and Virologically-Suppressed Male and Female HIV-Positive Patients Aged ≥18 Years Who Are Treatment-Experienced and Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks

Managing HIV well requires taking antiretroviral therapy (ART) every day, but many people living with HIV experience interruptions in their treatment. These pa…

HIV -1 InfectionHIV (Human Immunodeficiency Virus)HIV+1 more

Estimated

~$10 – $7,500

CAN Community HealthNCT07476339

Phase 1

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Higher Dose of the HCMV-HIV Vaccine Candidate VIR-1388, in HCMV-seropositive Adult Participants Without HIV

This study is to test an experimental HIV Vaccine. About 12 participants, aged 18-55 years and who already have cytomegalovirus (CMV) will take part in this st…

Cytomegalovirus (CMV)HIV (Human Immunodeficiency Virus)

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT07801456

C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States

The purpose of the CASCADE-3002 project is to improve access to cervical cancer screening among women with Human Immunodeficiency Virus (HIV) receiving care at…

Human Immunodeficiency Virus (HIV)Human Papillomavirus (HPV)Cervical Cancer+1 more

Estimated

~$10 – $750

UNC Lineberger Comprehensive Cancer CenterNCT07520188